Polypeptide hydrogels and uses related thereto

US9585915B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9585915-B2
Application numberUS-201514602839-A
CountryUS
Kind codeB2
Filing dateJan 22, 2015
Priority dateJan 23, 2014
Publication dateMar 7, 2017
Grant dateMar 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure relates to self-assembling peptides that form hydrogels comprising peptide sequences for the activation of signaling pathways. In certain embodiments, the disclosure relates to compositions comprising a recombinant polypeptide comprising a cell signaling sequence, e.g., JAG-1 sequence, fused to a hydrogel polypeptide sequence. In certain embodiments, the disclosure relates to methods of cell culture on three dimensional scaffolds/hydrogels composed of self-assembling peptides disclosed herein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A hydrogel comprising a recombinant polypeptide in combination with a hydrogel polypeptide, wherein the recombinant polypeptide comprises a cell signaling sequence, wherein the cells signal sequence comprises SEQ ID NO: 1, fused to a hydrogel polypeptide sequence, wherein the hydrogel polypeptide and the recombinant polypeptide are in a ratio of between 1:5 to 1:15 by weight, and wherein the hydrogel polypeptide and the recombinant peptide are 1.5% to 2.5% by weight to volume of the hydrogel. 2. The hydrogel of claim 1 comprising a saccharide at a concentration of between 100 nm to 500 mM. 3. The hydrogel of claim 1 comprising a buffer creating a pH of between 7.0 to 7.7. 4. The hydrogel of claim 1 , wherein the hydrogel further comprising a cardiac progenitor cell.

Assignees

Inventors

Classifications

  • C12N5/0657Primary

    Cardiomyocytes; Heart cells · CPC title

  • A61K35/34Primary

    Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44) · CPC title

  • Proteins · CPC title

  • containing domain for protein-protein interaction · CPC title

  • Notch; Delta; Jagged; Serrate · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9585915B2 cover?
This disclosure relates to self-assembling peptides that form hydrogels comprising peptide sequences for the activation of signaling pathways. In certain embodiments, the disclosure relates to compositions comprising a recombinant polypeptide comprising a cell signaling sequence, e.g., JAG-1 sequence, fused to a hydrogel polypeptide sequence. In certain embodiments, the disclosure relates to me…
Who is the assignee on this patent?
Univ Emory, Georgia Tech Res Inst
What technology area does this patent fall under?
Primary CPC classification C12N5/0657. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).